Category Archives: Start Ups

xenopat

Xenopat: Your Tumor in a Mouse

Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to offer services to companies developing new anticancer drugs and personalized cancer treatments. We had the pleasure of speaking with Dr. Anna Portela, CEO and co-founder, and Dr. Alberto Villanueva, CSO and co-founder. For more […]

telomeres

BioViva’s CEO Claims to Have Longer Telomeres After Gene Therapy

BioViva reported last week that the company’s CEO, Elizabeth Parrish, successfully reversed biological ageing after being treated with the biotech’s therapies. The Seattle-based company confirmed that Parrish reversed 20 years of telomere shortening thanks to an experimental gene therapy. BioViva aims to provide regenerative medicine solutions through gene and cell therapies. The company is involved in several research lines to […]

somagenics logo

Somagenics Secures NIH Funding for Degraded RNA Quantification Technology

Somagenics, a biotech company specialized in small RNA technologies, has received a second NIH grant to develop a method to quantify mRNA from degraded samples. The resQ-RNA is a quantitative real-time PCR of fragmented samples. The I-SBIR grant will be used to fund assays with a whole new range of RNA targets, including transcripts involved in […]

foldscope

Foldscope: A Paper Microscope that Costs $1

A team of researchers from Stanford University has developed a paper microscope that costs one dollar. Foldscope is printed in a sheet of paper and is folded into a functional shape, in a process akin to origami. The device can be easily mass-produced and is aimed to democratize science education and to provide a diagnostic tool […]

Patient iP Secures $2 Million Investment

Patient Identification Platform (PatientiP), a provider of clinical trial matching technology, has obtained $2 million in a Series A investment round. The company aims to facilitate the recruitment of individuals for clinical trials, which has become increasingly difficult due to complicated selection criteria, enrollment procedures and timelines. It is calculated that 50% of clinical trials […]

nanopore diagnostics logo

Nanopore Diagnostics Raises $600000 to Develop the iNDxer

American startup Nanopore Diagnostics has raised $600000 to develop The iNDxer, a device to detect bacterial infections. The money, provided by the Missouri Technology Corporation and other minor investors, will be allocated to conduct clinical trials that will validate the use of the Nanopore Diagnostics’ device by physicians. Nanopore Diagnostics CEO Tom Cohen was mistakenly […]

Fertility Could Be Controlled with a Switch

A team of German scientists is developing a new device to control fertility. The Bimek SLV is a valve that is fitted to the sperm ducts and interrupts sperm flow from the testicles to the ejaculatory ducts. The valve’s position can be modified any time manipulating a switch through the scrotum. The start-up is looking for investors and for volunteers […]